SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer, and chronic diseases.

SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way that minimizes delivery risk and enhances immunogenicity and efficacy.

The company’s current lead candidate is against Human Cytomegalovirus (HCMV), with clinical studies planned for this year.

England, UK

Oxford, UK

Oxfordshire, UK

SpyBiotech

We have a single purpose: to help Oxford’s outstanding scientists build and grow great businesses that can improve the world.

Oxford Science Enterprises

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Oxford Sciences Innovation Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Oxford Sciences Innovation network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Oxford Sciences Innovation company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Explore the positions available across Oxford Science Enterprises